Early Surgery with Burr Holes and Erythropoietin for Moyamoya Disease
Author Information
Author(s): Lee Yeonhu, Lee Jin Soo, Lee Seong-Joon, Hong Ji Man, Lim Yong Cheol
Primary Institution: Ajou University Hospital, Ajou University School of Medicine
Hypothesis
The study aims to validate the safety and efficacy of early intervention using multiple burr hole and erythropoietin therapy for patients with acute stroke episode of moyamoya disease or syndrome.
Conclusion
The study suggests that MBH and EPO combination therapy is an effective, minimally invasive treatment for patients with moyamoya disease or syndrome following an acute stroke episode.
Supporting Evidence
- 72.3% of early group hemispheres achieved Matsushima grade A.
- 63.8% of early group patients showed a significant reduction in basal moyamoya vessels.
- Only 5.5% in the early group experienced neurological worsening.
Takeaway
Doctors found that doing surgery early with special techniques helps patients with a brain condition called moyamoya disease feel better faster.
Methodology
The study retrospectively analyzed data from 70 patients who underwent MBH and EPO therapy, comparing outcomes based on the timing of surgery.
Potential Biases
Potential biases may arise from the single-center design and retrospective nature of the study.
Limitations
The study is limited by its retrospective design and lack of a control group.
Participant Demographics
The cohort included 70 patients with moyamoya disease or syndrome, with a mean age of 43.4 years.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI: 1.46–8.45
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website